32199-2

Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe

Discouraged

Status Information

Status

DISCOURAGED

Comment

Testing for C. trachomatis and N. gonorrhoeae by probe alone is no longer recommended; nucleic acid amplification testing is preferred. [PMID: 24622331]

Part Description

LP14316-1   Neisseria gonorrhoeae
Neisseria gonorrhoeae are gram-negative cocci usually seen in pairs with the adjacent sides flattened. Pili, filament-like appendages, extend from the cell surface and have a role in adherence. Gonorrhea is usually acquired by sexual contact. Men and women aged 15-29 have the highest incidence of gonorrhea. Number of sexual partners, sexual practices and preference, condom use and population mobility contribute to disease incidence. The most frequent sites are the cervix, urethra, rectum, pharynx and conjunctiva. The most common symptom in men is discharge that may be scanty and clear or cloudy to copious and purulent, and often dysuria. Asymptomatic men are an important reservoir for transmission. Endocervical infection is the most common form of infection in women. Ocular infections occur most commonly in newborns who are exposed in the birth canal and can lead to corneal scarring or perforation. Gonococcal bacteremia may lead to disseminated infection including pelvic inflammatory disease in as many as 15 percent of women, leading to an increased probability of infertility and ectopic pregnancy. While antibiotics have successfully treated gonorrhea for decades, N. gonorrhoeae has developed antimicrobial resistance to every drug used for treatment. The Centers for Disease Control and Prevention recommends combination therapy using two antimicrobials with different mechanisms of action (e.g., a cephalosporin plus azithromycin) to improve treatment efficacy and potentially slow the spread of resistance to cephalosporins. [NCBI Books:NBK7650] [CDC:std/tg2015/gonorrhea] Source: Regenstrief LOINC

Fully-Specified Name

Component

Neisseria gonorrhoeae rRNA

Property

PrThr

Time

Pt

System

Urethra

Scale

Ord

Method

Probe

Additional Names

Short Name

N gonorrhoea rRNA Urth Ql Probe

Display Name

N. gonorrhoeae rRNA Probe Ql (Urethra)

Consumer Name Alpha Get Info

Neisseria gonorrhoeae, Urethra

Basic Attributes

Class

MICRO

Type

Laboratory

First Released

Version 2.07

Last Updated

Version 2.63

Change Reason

The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Discouraged as part of the project to update LOINC chlamydia and gonorrhea terms based on the 2014 CDC "Recommendations for the Laboratory-Based Detection of Chlamydia trachomatis and Neisseria gonorrhoeae" [PMID: 24622331]

Order vs. Observation

Both

Member of these Panels

Member of these Groups Get Info

Language Variants Get Info

Related Names

• DNA NUCLEIC ACID PROBE
• DNA probe
• GC
• Genital tract
• Gono
• Gonorrhea
• ID
• Infectious Disease
• InfectiousDisease
• Microbiology
• N gonorrhoea
• N gonorrhoeae
• Ordinal
• Point in time
• PR
• QL
• Qual
• Qualitative
• Random
• ribosomal RNA
• Screen
• Urth

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=32199-2

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.